Insider Selling: CME Group Inc. (NASDAQ:CME) Director Sells $132,675.00 in Stock

CME Group Inc. (NASDAQ:CMEGet Free Report) Director Charles P. Carey sold 500 shares of CME Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the completion of the sale, the director now owns 4,900 shares of the company’s stock, valued at approximately $1,300,215. The trade was a 9.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

CME Group Trading Down 0.5%

Shares of CME Group stock opened at $269.50 on Friday. The stock has a fifty day simple moving average of $272.73 and a 200 day simple moving average of $254.28. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $290.79. The company has a market capitalization of $97.12 billion, a P/E ratio of 27.87, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The business had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the prior year, the company posted $2.50 earnings per share. CME Group’s revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be issued a dividend of $1.25 per share. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.86%. CME Group’s dividend payout ratio (DPR) is currently 50.30%.

Institutional Investors Weigh In On CME Group

Several institutional investors have recently bought and sold shares of the stock. eCIO Inc. purchased a new position in CME Group in the first quarter worth $236,000. Militia Capital Partners LP purchased a new position in CME Group in the first quarter worth $210,000. Invst LLC purchased a new position in CME Group in the first quarter worth $817,000. Modern Wealth Management LLC boosted its position in CME Group by 6.0% in the first quarter. Modern Wealth Management LLC now owns 12,370 shares of the financial services provider’s stock worth $3,282,000 after purchasing an additional 705 shares during the last quarter. Finally, Strs Ohio purchased a new position in CME Group in the first quarter worth $29,109,000. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Piper Sandler lifted their target price on CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a report on Tuesday, April 8th. Oppenheimer boosted their price objective on CME Group from $282.00 to $300.00 and gave the company an “outperform” rating in a report on Wednesday, June 4th. Morgan Stanley boosted their price objective on CME Group from $301.00 to $304.00 and gave the company an “overweight” rating in a report on Thursday, April 24th. Keefe, Bruyette & Woods boosted their price objective on CME Group from $265.00 to $273.00 and gave the company a “market perform” rating in a report on Thursday, April 24th. Finally, JPMorgan Chase & Co. decreased their price objective on CME Group from $223.00 to $211.00 and set an “underweight” rating for the company in a report on Thursday, April 24th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, CME Group currently has an average rating of “Hold” and a consensus price target of $258.20.

View Our Latest Stock Report on CME Group

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.